Clinical Study
Cardiovascular Risk and Metabolic Syndrome Characteristics in Patients with Nonfunctional Pituitary Macroadenoma
Table 2
Clinical and biochemical characteristics of patients with NFPMA.
| | At diagnosis | At the last visit | |
| | Age (y), mean ± SD | 54.3 ± 13.7 | 61.9 ± 10.5 | 0.01 | | Weight (kg), mean ± SD | 76.20 ± 13 | 74.7 ± 13.6 | 0.37 | | BMI (kg/m2), median (IR) | 29.3 (26.5–31.4) | 29 (26.4–32) | 0.49 | | Waist circumference (cm), mean ± SD | Male: 92.1 ± 12.6 | Male: 91.9 ± 13.5 | 0.32 | | Female: 89.6 ± 10.3 | Female: 90.3 ± 11.0 | 0.43 | | Glucose (mg/dL), median (IR) | 94 (86–99) | 96 (85–115) | 0.20 | | Insulin (UI/dL), median (IR) | 13.7 (8.1–25) | 16 (7.5–31.5) | 0.57 | | HOMA-IR, median (IR) | 3.0 (1.8–6.4) | 4.9 (1.9–16.6) | 0.41 | | HbA1c (%), median (IR) | 6.3 (5.8–6.5) | 6 (5.7–7.4) | 0.89 | | Systolic blood pressure (mmHg), mean ± SD | 117 ± 14 | 114 ± 14.5 | 0.53 | | Diastolic blood pressure (mmHg), mean ± SD | 74.6 ± 9.4 | 70 ± 15.5 | 0.26 | | Total cholesterol (mg/dL), mean ± SD | 210 ± 46 | 199 ± 35 | 0.08 | | HDL-C (mg/dL), median (IR) | 43 (35–52) | 45 (38–50) | 0.21 | | LDL-C (mg/dL), mean ± SD | 121.8 ± 50 | 120 ± 31 | 0.68 | | Triglycerides, mean ± SD | 221 ± 121 | 171 ± 67 | 0.02 |
|
|
